Alkim Alkali Kimya AS (ALKIM) fair value: what the stock is really worth
As of Oct 28, 2026: fair value (intrinsic value) of Alkim Alkali Kimya AS stock TRY 13.28, price TRY 9.57, upside +38.8%, quality 23 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value 30%+ above price?Yes
Quality 50+?No
In an uptrend?No
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 29, 2026.
How to read this chart
60‑month range 6.87 TRY – 23.98 TRY · fair‑value band 10.28 TRY – 16.28 TRY · the 9.57 TRY price screens below the 13.28 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 29, 2026.
Follow Alkim Alkali Kimya AS in your weekly email
Every Wednesday you see whether Alkim Alkali Kimya AS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Alkim Alkali Kimya A.S., together with its subsidiaries, engages in the production and sale of paper products in Turkey. The company offers first pulp paper, coated, and photocopy paper. It also provides sodium sulphate, potassium sulphate, salt, and magnesium chloride liquid.
Show moreShow less
In addition, it offers insurance brokerage services. The company was founded in 1948 and is headquartered in Istanbul, Turkey.
Stock analysis
Alkim Alkali Kimya AS (ALKIM) currently trades at 9.57 TRY, while our model-based Fair Value estimate is 13.28 TRY, implying the stock looks roughly 27.9% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 6.64 TRY per share, and 1 of the 6 models we run sit above the 9.57 TRY price.
Bear case: the Asset-Based group reads lowest at 1.64 TRY, and 5 of the 6 models stay below the price. Data coverage for this calculation is low.
Scenario range: 10.28 TRY (bear) to 16.28 TRY (bull), the price of 9.57 TRY sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 23/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Alkim Alkali Kimya AS reported revenue of 5.1B TRY in FY2025 versus 1.1B TRY in FY2021, a compound +46.9%/yr. Reported net income was −408M TRY in FY2025.
Key figures
Market cap 2.9B TRY (≈ $57.6M) Micro · P/S ratio 0.58 · EPS (TTM) −1.56 TRY · Net margin −9.0% · Return on equity −9.9% · Return on assets (EBIT) 18.4% · Operating margin 1.5% · Revenue (TTM) 5.0B TRY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 17 out of 100 (medium confidence).
What moves the price
The share trades about 55% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 32% fair-value upside, at 39%, ALKIM screens cheaper than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (1.64 TRY to 13.80 TRY). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear10.28 TRYFair Value 13.28 TRYBull16.28 TRY
Price 9.57 TRY · Upside +38.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−16.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+46.6%
Start year 2020 (pandemic). Over 10 years: +34.6% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
27.6% (2020) → 2.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Paper & Paper Products · 116 stocks
Beats the industry median on 4/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score23 · Bottom 25%
Fair Value upside+38.8% · Above median
Profitability
Return on assets−6.5% · Bottom 25%
Net margin (12 months)−9.0% · Bottom 25%
Operating margin (12 months)1.5% · Below median
Growth and dividend
Revenue growth (quarter YoY)−2.0% · Bottom 25%
Balance sheet
Debt / equity0.02× · Lowest 25%
Valuation Multiplesvs Paper & Paper Products median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Alkim Alkali Kimya AS Fair Value". https://www.fairvalue-calculator.com/stock/ALKIM
Frequently asked questions
Is Alkim Alkali Kimya AS (ALKIM) overvalued or undervalued?
As of Oct 29, 2026, our model estimates a fair value of 13.28 TRY versus a price of 9.57 TRY, about +39% upside (undervalued).
What is the fair value of ALKIM?
Our model-based fair value for Alkim Alkali Kimya AS is 13.28 TRY (as of Oct 29, 2026), built from audited fundamentals. The current price: 9.57 TRY.
What is the quality score of ALKIM?
Alkim Alkali Kimya AS has a Quality Score of 23/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Alkim Alkali Kimya AS (ALKIM)?
Our model-based price target is the fair value of 13.28 TRY (as of Oct 29, 2026) from 6 valuation models. Cautious scenario 10.28 TRY, optimistic scenario 16.28 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Alkim Alkali Kimya AS stock forecast for 2026?
Our models put fair value at 13.28 TRY, about +39% upside versus a price of 9.57 TRY (undervalued). Cautious scenario 10.28 TRY, optimistic scenario 16.28 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Alkim Alkali Kimya AS (ALKIM)?
Alkim Alkali Kimya AS reported trailing-twelve-month revenue of about 5.0B TRY (latest available figure, as of Oct 29, 2026).
What is the intrinsic value of Alkim Alkali Kimya AS (ALKIM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Alkim Alkali Kimya AS it is 13.28 TRY per share (as of Oct 29, 2026), against a price of 9.57 TRY. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Alkim Alkali Kimya AS stock overvalued or undervalued in 2026?
As of Oct 29, 2026, ALKIM trades below its calculated fair value: price 9.57 TRY, fair value 13.28 TRY, a gap of about +39% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALKIM?
No. The price is what the market pays today (9.57 TRY); the fair value is what the company's own numbers justify (13.28 TRY). For Alkim Alkali Kimya AS the two are 3.71 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Alkim Alkali Kimya AS worth?
The market values Alkim Alkali Kimya AS at about 2.9B TRY (market capitalisation, as of Oct 29, 2026). Per share that is 9.57 TRY; our models calculate a fair value of 13.28 TRY per share.
What do the bullish and bearish scenarios say about ALKIM?
Our models span a range for Alkim Alkali Kimya AS: cautious scenario 10.28 TRY, base 13.28 TRY, optimistic 16.28 TRY per share (as of Oct 29, 2026, price 9.57 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Alkim Alkali Kimya AS (ALKIM)?
Balance-sheet figures for Alkim Alkali Kimya AS (as of Oct 29, 2026): return on equity −9.9%, debt of 0.02 per unit of equity. They feed the Quality Score of 23/100, which measures business quality independently of the share price.
How far is ALKIM from its 52-week high?
Alkim Alkali Kimya AS trades at 9.57 TRY, about 55% below its 52-week high of 21.04 TRY and 1% above the low of 9.46 TRY (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of 13.28 TRY is for.
Which stocks are comparable to Alkim Alkali Kimya AS?
From the same area (Basic Materials) we also value UPM-Kymmene Oyj, Suzano S.A, Shandong Sunpaper Co, Empresas CMPC S.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Alkim Alkali Kimya AS stock attractive at the current price?
The data as of Oct 29, 2026: price 9.57 TRY, calculated fair value 13.28 TRY (+39%), Quality Score 23/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALKIM calculated?
We run Alkim Alkali Kimya AS through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 13.28 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. Alkim Alkali Kimya AS currently trades 28 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Alkim Alkali Kimya AS (ALKIM)?
The closing price on Oct 28, 2026 was 9.57 TRY. Our model-based fair value is 13.28 TRY, about +39% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Alkim Alkali Kimya AS right now?
The large discount to fair value meets weak quality (23/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (10.28 TRY). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Alkim Alkali Kimya AS
How large is the market capitalisation of Alkim Alkali Kimya AS (ALKIM)?
The market capitalisation of Alkim Alkali Kimya AS is 2.9B TRY (≈ $57.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Alkim Alkali Kimya AS (ALKIM)?
The price-to-sales ratio of Alkim Alkali Kimya AS is 0.58 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Alkim Alkali Kimya AS (ALKIM)?
Earnings per share at Alkim Alkali Kimya AS are −1.56 TRY. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Alkim Alkali Kimya AS (ALKIM)?
The net margin of Alkim Alkali Kimya AS is −9.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Alkim Alkali Kimya AS (ALKIM)?
The return on equity (ROE) of Alkim Alkali Kimya AS is −9.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Alkim Alkali Kimya AS (ALKIM)?
On an EBIT basis the return on assets of Alkim Alkali Kimya AS is 18.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Alkim Alkali Kimya AS (ALKIM)?
The operating margin of Alkim Alkali Kimya AS is 1.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Alkim Alkali Kimya AS (ALKIM)?
Revenue at Alkim Alkali Kimya AS is growing −2.0% versus a year earlier (3y avg +22.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Alkim Alkali Kimya AS (ALKIM)?
Earnings per share at Alkim Alkali Kimya AS are growing +38.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Alkim Alkali Kimya AS (ALKIM) generate?
The free cash flow of Alkim Alkali Kimya AS is −339M TRY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Alkim Alkali Kimya AS in the live analysis
One click puts Alkim Alkali Kimya AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 29, 2026